Hepatitis Weekly articles from December 2003

Hepatitis Weekly archives from December 2003

Interferon improves insulin dynamics in chronic hepatitis B and C responders.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Interferon improves insulin dynamics in chronic hepatitis B and C responders. According to recent research from Taiwan, "this study aimed at elucidating the effects of interferon (IFN)-alpha on...

Bone marrow-derived cells offer little hope for repairing damaged livers.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Bone marrow-derived cells offer little hope for repairing damaged livers. "We have tested the ability of bone marrow (BM) cells (BMCs) to form hepatocytes in liver injury models. We used three...

Methadone users need access to orthotopic liver transplantations.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Methadone users need access to orthotopic liver transplantations. According to a study from the United States, "cirrhosis resulting from hepatitis C virus is presently the most common indication...

Patients with liver diseases report having upper abdominal pain symptoms.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Patients with liver diseases report having upper abdominal pain symptoms. "Chronic hepatitis has many causes. Symptoms include upper abdominal pain. To allow for a better understanding of this pain...

Where livers and kidneys are both needed liver transplants should be done first.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Where livers and kidneys are both needed liver transplants should be done first. "Experience with combined liver-kidney transplantation (L-KTx) has increased, but controversy regarding this...

Patients with alcoholic etiologies fare worse in a study of steatohepatitis.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Patients with alcoholic etiologies fare worse in a study of steatohepatitis. "A previous publication analyzed the clinicopathological characteristics of 105 patients with steatohepatitis: 32...

Company updates positive clinical data on multiple antisense drugs.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Isis Pharmaceuticals, Inc., (ISIS) announced positive data from clinical trials of four antisense drugs for the treatment of four diseases. Final results from phase II studies of ISIS 104838 in...

Gene therapy containing p53 combines with CDDP to arrest liver tumor growth.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Gene therapy containing p53 combines with CDDP to arrest liver tumor growth. "Surgical resection is thought to be the best treatment for liver carcinoma, including hepatocellular carcinoma and...

Hepatitis B virus genes promote liver cancer in chronic hepatitis C patients.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Hepatitis B virus genes promote liver cancer in chronic hepatitis C patients. According to recent research published in the journal Digestive Diseases and Sciences, "the hepatitis B virus (HBV) gene...

Tissue regeneration may drive HCV recurrence after liver transplantation.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Tissue regeneration may drive HCV recurrence after liver transplantation. "Living donor liver transplantation (LDLT) is an option for patients with end-stage liver disease or hepatoma caused by...

Pennsylvania partnership announces agreement to build relationship with Roche.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Health Network Laboratories (HNL), a regional provider of medical diagnostics in Pennsylvania and New Jersey, announced a 5-year strategic alliance agreement with Roche Diagnostics. Together the...

Long-term rosiglitazone improves the markers of nonalcoholic steatohepatitis.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Long-term rosiglitazone improves the markers of nonalcoholic steatohepatitis. "Insulin resistance (IR) commonly is associated with nonalcoholic steatoliepatitis (NASH). To establish whether IR...

Actimmune maker announces third quarter financial results.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- InterMune, Inc., (ITMN) announced results from operations for the third quarter and 9 months ended September 30, 2003. For the third quarter of 2003, InterMune recorded total net product sales of...

Outcomes with hepatitis C- and B-core antibody-positive grafts are good.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Outcomes with hepatitis C- and B-core antibody-positive grafts are good. According to a study from the United States, "the use of hepatitis B core antibody (HBcAb)- and hepatitis C virus antibody...

Keeping DC immaturity may induce tolerance for transplant of hematopoietic cells.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Continuing dendritic cell immaturity stage may be enough to induce a tolerogenic state for transplant of hematopoietic cells. "Recent evidence suggests that recipient as well as donor dendritic...

New study finds universal vaccination would prevent disease and save lives.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- A U.S. hepatitis A immunization policy would prevent a significant number of debilitating cases of the disease and deaths associated with it, according to a new study. Researchers examined the...

Aspergillus niger effective host for virus-like particle production.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Scientists have demonstrated that Aspergillus niger is an effective host for virus-like particle production, using the hepatitis B surface antigen as a model. "The filamentous fungus Aspergillus...

Companies enter hepatitis C virus license agreement.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Rigel Pharmaceuticals, Inc., (RIGL) has entered into a nonexclusive licensing agreement with Chiron Corporation (CHIR) granting Rigel a license to discover, develop, and commercialize small molecule...

Pharmaceutical company to initiate phase III clinical trials for Viramidine.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- ICN Pharmaceuticals, Inc., (ICN) announced that it has decided, following a meeting with the U.S. Food and Drug Administration (FDA), to initiate phase III studies of its antiviral compound, Viramidine....

Researchers reveal essential component of immunity to liver-destroying virus.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers at Columbus Children's Research Institute (CCRI) on the campus of Columbus Children's Hospital have identified a key component of protective immunity against the hepatitis C virus, the major...

Nasal or rectal administration of glycyrrhizin offers good bioavailability.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Nasal or rectal administration of glycyrrhizin offers good bioavailability. According to recent research published in the International Journal of Pharmaceutics, "the purpose of this study was to...

Interferon-alpha down-regulates collagen production and stems liver fibrosis.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Interferon-alpha down-regulates collagen production and stems liver fibrosis in lab animals. According to a study from Japan, "the equilibrium between the production and degradation of collagen is...

Liver cirrhosis with inoperable liver cancer treated by intratumor ethanol, IL-2.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Liver cirrhosis with inoperable hepatocellular carcinoma may be controllable with intratumor injection of alcohol and IL-2. According to published research from Bulgaria, "a case of an inoperable...

Net Force signs letter of intent to acquire Chinese biotech company.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Net Force Systems, Inc., announced that Net Force has entered into a letter of intent to acquire 100% of the issued and outstanding shares of Tangshan Yian Biological Engineering Co., Ltd., through the...

Healthcare workers experience a decline in blood and body fluid exposures.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Healthcare workers experience a decline in blood and body fluid exposures. "The risk of accidental blood and body fluid (131317) exposure is a daily concern for health care workers throughout the...

Reactive oxygen species exacerbate the effects of hepatitis B virus X protein.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Reactive oxygen species exacerbate the effects of hepatitis B virus X protein. According to published research from South Korea, "HBx (hepatitis B virus X) viral oncoprotein is a multifunctional...

Saikosaponins from Bupleurum exhibit antiviral and anticancer properties.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Saikosaponins from Bupleurum exhibit antiviral and anticancer properties. "Saikosaponins, the main active constituents of Bupleurum spp., have been shown to possess immunomodulatory,...

Hepatitis C virus core protein assembles in the nucleus of yeast.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus core protein assembles in the nucleus of yeast. "The relationship between HCV core protein (HCcAg) processing and the structural composition and morphogenesis of nucleocapsid-like...

Crystalline particles seen in University of Wisconsin perfusion solution.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- University of Wisconsin solution for transplant organ storagecontains crystalline particles. According to recent research from the United States, "we have demonstrated the presence of crystalline...

HCV recurrence reflects low sequence diversity after liver transplantation.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- HCV recurrence reflects low sequence diversity after liver transplantation. "Hepatitis C virus (HCV) shows remarkable genetic variation in both populations and individuals, in whom it circulates as...

Neither liver transplantation nor HCV contraindicate renal transplant.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Neither liver transplantation nor HCV contraindicate renal transplant. "We report a case in which a living related renal transplantation was successfully performed for end-stage renal disease that...

Alternative translation schemes control hepatitis C ARFP/F/core +1 coding.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Alternative translation schemes control hepatitis C ARFP/F/core +1 protein coding. According to a study from Greece, "hepatitis C virus (HCV)-1 produces a novel protein, known as ARFP, F, or core...

Hepatitis C envelope glycoprotein E2 requires heparan sulfate for cell binding.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Hepatitis C envelope glycoprotein E2 requires heparan sulfate for cell binding. According to recent research from Germany, "the conservation of positively charged residues in the N terminus of the...

Sodium stibogluconate inhibits authentic hepatitis C virus replication.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Sodium stibogluconate inhibits authentic hepatitis C virus replication. "Using a hepatitis C virus (HCV) subgenomic RNA replicon system, drugs currently being used to treat other human diseases were...

Chronic hepatitis C progression to cirrhosis associates with iron accumulation.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Chronic hepatitis C progression to cirrhosis associates with iron accumulation in the liver. According to a study from the United States, "hepatic iron deposition is common in patients with chronic...

Some non-steroidal anti-inflammatory drugs have a higher risk for liver injury.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Certain non-steroidal anti-inflammatory drugs have a higher risk for liver injury. According to recent research published in the QJM - an International Journal of Medicine, "non-steroidal...

Interferon therapy for HCV-infected patients warrants psychological assessments.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Interferon therapy for HCV-infected patients warrants psychological assessments. "This article presents a prospective study of 71 patients infected with chronic viral hepatitis C and treated with...

Serum soluble Fas levels rise in advanced stages of HCV-induced liver disease.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Serum soluble Fas levels rise in advanced stages of HCV-induced liver disease. "We aimed to determine serum soluble Fas antigen (sFas) levels at various stages of hepatitis C virus (HCV)-induced...

Pegylated interferon offers several advantages over standard interferon.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Pegylated interferon offers several advantages over standard interferon. According to a study from Spain, "modification of the pharmacokinetic profile of interferon-alpha (IFN-alpha) through...

Hepatitis C virus-positive renal donations heighten mortality risk.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus-positive renal donations heighten mortality risk. According to published research from the United States, "kidneys from donors who are positive for hepatitis C virus (DHCV) have...

Post-kidney transplant ANCA-positive glomerulonephritis may be treatable.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Post-kidney transplant ANCA-positive glomerulonephritis may be treatable if it occurs. "Recurrence of crescentic necrotizing glomerulonephritis after renal transplantation is rare. Successful renal...

In non-HLA identical bone marrow transplant, T-cell incompatibility is high risk.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- In non-HLA identical, minimally T cell depleted pediatric bone marrow transplant, the T and not the NK cell incompatibility led to increased GVHD and death. "Natural killer (NK) cell alloreactivity...

Lamivudine-resistant patients develop compensatory mutations during therapy.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Lamivudine-resistant patients develop compensatory mutations during therapy. "Therapy of chronic hepatitis B virus (HBV) infection with the polymerase inhibitor lamivudine frequently is associated...

Ceftriaxone treats culture-negative neutrocytic ascites in cirrhotic patients.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Ceftriaxone treats culture-negative neutrocytic ascites in cirrhotic patients. "The goal of this study is to establish whether 5 days of ceftriaxone treatment was sufficient to cure culture-negative...

Gen-Probe, partner amend blood screening agreement to set fixed revenue shares.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Gen-Probe, Inc., (GPRO) and Chiron Corp. (CHIR) announced they have agreed to amend their world-wide blood screening collaboration agreement in order to adopt permanent, fixed revenue shares for each...

Nonexclusive HCV license granted to Vertex.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Chiron Corporation (CHIR) announced that it has granted a nonexclusive license to Vertex Pharmaceuticals for the research, development, and commercialization of therapeutics against certain hepatitis C...

Infectious-disease company nears product commercialization, approves stock split.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Immtech International, Inc., (IMM) announced that it is in the process of acquiring a portion of a building to prepare for Immtech's transition into product commercialization. The building is...

New York Assembly pushes for state oversight of prison healthcare.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- New York's Democratic state legislators and prisoner advocates promoted legislation on November 14, 2003, to give the state Health Department oversight over some aspects of the healthcare system for the...

Analyses of bile-acid transport reveal how toxic drugs are to the liver.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Analyses of bile-acid transport reveal how toxic drugs are to the liver. According to recent research published in the journal Toxicological Sciences, "inhibition of canalicular bile acid efflux by...

AIDS vaccine developer reports increased cash due to financing.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN) announced its financial results for the third quarter ended September 30, 2003. During the quarter, cash and cash equivalents increased by $2.2 million to an ending balance...

Prestara maker reports increased losses, decreased revenues, in third quarter.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Genelabs Technologies, Inc., (GNLB) reported revenues of $0.7 million and a net loss of $4.8 million, or $0.08 per share, for the quarter ended September 30, 2003. This compares to revenues of $0.8...

Glucose screening is advised for nonalcoholic fatty liver disease patients.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Oral glucose screening is advised for nonalcoholic fatty liver disease patients. "Nonalcoholic fatty liver disease (NAFLD) is frequently associated with type 2 diabetes mellitus, obesity, and...

Liver cells express hepatitis B virus at different levels.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Liver cells express hepatitis B virus at different levels. "Hepatitis B virus (hepadnavirus) infections are maintained by the presence of a small and regulated number of episomal viral genomes...

Consumers advised that recent outbreaks have been associated with green onions.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has been working closely with the U.S. Centers for Disease Control and Prevention (CDC), several states, and Mexican authorities to investigate possible links...

Safety trial initiated for experimental hepatitis C drug treatment.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Rigel Pharmaceuticals, Inc., (RIGL) has initiated an escalating single dose safety trial of R803, an experimental drug to treat the hepatitis C virus (HCV). The goal of this trial is to establish...

New investigational vaccine tested for first time in humans.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- With an estimated 170 million people around the world already infected with hepatitis C, St. Louis University is testing, for the first time in humans, an investigational vaccine that researchers hope...

Research results support use of histamine in treatment of hepatitis C.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Maxim Pharmaceuticals (MAXM) announced the publication of results from preclinical research suggesting that histamine, the active agent in its lead drug candidate Ceplene, protects critical human immune...

HCV core protein modulates immune response against HBV surface antigen.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- The hepatitis C virus core protein modulates the immune response against the hepatitis B virus surface antigen in mice. According to recent research published in the journal Biochemical and...

Viral hepatitis markers found in a Canadian First Nations Community.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Researchers found viral hepatitis markers in a large percentage of a Canadian First Nations Community. According to recent research from Canada, "Serological markers for hepatitis A (HAV), B (HBV),...

IVIG may be particularly useful therapy for group A streptococcal septicemia.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- IVIG therapy may be particularly useful for treating group A streptococcal sepsis. According to recent research published in the Scandinavian Journal of Infectious Diseases, "immunotherapy targeted...

Etanercept therapy for arthritis may induce autoimmune-type responses, uveitis.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Etanercept therapy for juvenile arthritis may induce autoimmune type responses including sarcoidosis, rash, liver granulomas, and uveitis. According to a study from the United States, "we report the...

Interleukin-4 suppresses HBV replication in hepatocellular carcinoma cells.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Interleukin-4 suppresses HBV replication in hepatocellular carcinoma cells. "Interleukin (IL)-4 has been known as a Th2 cytokine and can act on B cells, T cells, and monocytes. In this study we...

Second living donor liver transplant increases PGP, increasing cyclosporine need.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- A second living donor liver transplant following rejection may increase enterocyte P-glycoprotein, thus lowering cyclosporine bioavailability and increasing dose. "We evaluated levels of intestinal...

Disseminated B-cell lymphoma in animal model is controlled by [superscript]213Bi-antiCD74.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Disseminated B-cell lymphoma in animal model is reduced, cured by [superscript]213Bi-antiCD74 monoclonal antibody therapy. According to published research from the United States, "a...

Occult HBV and alcohol power liver cancer in non-B, non-C hepatitis patients.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Occult HBV and alcohol power liver cancer in non-B, non-C hepatitis patients. "Few studies have examined the etiology of hepatocellular carcinoma (HCC) in patients without hepatitis virus infection....

Primary liver cancers overexpress X-linked inhibitor of apoptosis.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Primary liver cancers overexpress X-linked inhibitor of apoptosis. "The X-linked inhibitor of apoptosis (XIAP) is a member of a novel family of inhibitors of apoptosis. Since suppression of...

Brazilian control program is found effective in greatly reducing schistosomiasis.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Brazilian control program is found effective in reducing schistosomiasis substantially, but some residual infection still occurs. According to recent research from Brazil, "a field survey on...

Platelet counts increase in thrombocytopenia patients given ursodeoxycholic acid.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Idiopathic thrombocytopenia purpura patients may benefit from ursodeoxycholic acid treatment; platelet counts increase. According to recent research from Japan, "ursodeoxycholic acid (UDCA) is...

Hepatitis C virus persistence may depend on MHC class I interference.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus persistence may depend on MHC class I interference. "The hepatitis C virus (HCV) causes chronic hepatitis in most infected individuals by evading host immune defenses. In this...

Hepatitis C virus cell entry requires co-receptors.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus cell entry requires co-receptors. "Several cell surface molecules have been proposed as receptor candidates, mediating cell entry of hepatitis C virus (HCV) on the basis of their...

Hepatitis E virus immunoglobulin G assays track viral epidemiology.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Hepatitis E virus immunoglobulin G assays track viral epidemiology. According to researchers in the Peoples Republic of China, "we have evaluated four hepatitis E virus (HEV) specific antibody...

Pregnant gilts don't acquire fulminant swine hepatitis E virus infection.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Pregnant gilts don't acquire fulminant swine hepatitis E virus infection. "To determine the effect of swine hepatitis E virus (HEV) infection on pregnant gilts, their fetuses, and offspring, 12...

Company gets $4.3 from NHLBI to pursue licensure of WNV nucleic acid test.
December 8, 2003... 2003 DEC 8 - (NewsRx.com & NewsRx.net) -- Gen-Probe, Inc., (GPRO) has received $4.3 million in supplemental contract funding from the National Heart, Lung, and Blood Institute (NHLBI) of the U.S. National Institutes of Health (NIH) to support...

Youth with non-organ-specific autoantibodies may not benefit from interferon.
December 15, 2003... 2003 DEC 15 - (NewsRx.com & NewsRx.net) -- Youth with non-organ-specific autoantibodies may not benefit from interferon. "We evaluated the prevalence and clinical significance of non-organ-specific autoantibodies (NOSAs) in 47 hepatitis C...

Liver transplantees older than 60 have reduced survival and more cancer.
December 15, 2003... 2003 DEC 15 - (NewsRx.com & NewsRx.net) -- Liver transplantees older than 60 have reduced survival and more cancer. "Older age is not considered a contraindication for liver transplantation, but age-related morbidity may be a cause of...

Sarcomatous lesions can form after ablative therapy for primary liver cancer.
December 15, 2003... 2003 DEC 15 - (NewsRx.com & NewsRx.net) -- Sarcomatous lesions can form after ablative therapy for primary liver cancer. "We report a case involving well-differentiated hepatocellular carcinoma (HCC) developing to HCC with sarcomatous...

Fatigue warrants clinical attention in patients with chronic hepatitis C.
December 15, 2003... 2003 DEC 15 - (NewsRx.com & NewsRx.net) -- Fatigue warrants clinical attention in patients with chronic hepatitis C. According to recent research from Canada, "The chronic hepatitis C virus (HCV) has traditionally been impossible to treat....

Serum KL-6 is a pulmonary fibrosis marker in patients with hepatitis C virus.
December 15, 2003... 2003 DEC 15 - (NewsRx.com & NewsRx.net) -- Serum KL-6 is a pulmonary fibrosis marker in patients with hepatitis C virus. According to a study from Japan, "the aim of this study was to evaluate when the serum level of KL-6, a sensitive...

CMV-specific T cells useful in combating post-transplant CMV infection.
December 15, 2003... 2003 DEC 15 - (NewsRx.com & NewsRx.net) -- Therapy with CMV-specific T cells to combat CMV infection following transplant is effective in many patients. According to published research from England, "adoptive transfer of CMV-specific T...

Nitroimadole derivatives cause liver injury resembling acute hepatitis.
December 15, 2003... 2003 DEC 15 - (NewsRx.com & NewsRx.net) -- Nitroimadole derivatives cause liver injury resembling acute hepatitis. "Metronidazole and ornidazole, synthetic nitroimidazole derivatives, are used in the treatment of infections caused by...

Serum hepatitis B virus DNA levels fluctuate during chronic infection.
December 15, 2003... 2003 DEC 15 - (NewsRx.com & NewsRx.net) -- Serum hepatitis B virus DNA levels fluctuate during chronic infection. "The aims of this study were to investigate serum hepatitis B virus (HBV) DNA levels at different clinical stages in patients...

Report: Georgia, North Carolina hepatitis strains linked.
December 15, 2003... 2003 DEC 15 - (NewsRx.com & NewsRx.net) -- A North Carolina outbreak of hepatitis A probably came from green onions, which also have been blamed for outbreaks linked to restaurants in Georgia, Tennessee and Pennsylvania, according to a...

Vitamin D receptor gene mutation linked to chronic periodontitis.
December 15, 2003... 2003 DEC 15 - (NewsRx.com & NewsRx.net) -- A vitamin D receptor gene mutation associated with increased susceptibility to TB and HBV infection is also linked to a heighted risk of chronic periodontitis (CP). According to published research...

Hepatitis C infection uncommon among HIV-positive, -negative women in New York.
December 15, 2003... 2003 DEC 15 - (NewsRx.com & NewsRx.net) -- Hepatitis C infection is uncommon among HIV-positive and -negative women in New York. "Individuals infected with human immunodeficiency virus type 1 (HIV-1) are frequently coinfected with...